Concord Drugs

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue10.3913.6110.2816.9937.90
Expenses10.3413.4510.0116.6937.16
EBITDA1.051.021.100.951.49
Operating Profit0.670.650.760.641.15
Profit Before Tax0.060.160.270.300.75
Net Profit0.040.120.190.220.53
Financial Ratios
Operating Profit Margin10.11%7.49%10.70%5.54%3.96%
Net Profit Margin0.38%0.88%1.85%1.30%1.40%
Earning Per Share (Diluted)0.040.120.190.160.47
Dividends Per Share0.000.000.000.000.00